[HTML][HTML] Hypertension as a surrogate marker for the activity of anti-VEGF agents
O Mir, S Ropert, J Alexandre… - Annals of …, 2009 - annalsofoncology.org
found that the occurrence of hypertension [grade‡ 3 according to the National Cancer
Institute—Common Toxicity Criteria (NCI-CTC)[13]] was associated with a higher response …
Institute—Common Toxicity Criteria (NCI-CTC)[13]] was associated with a higher response …
[引用][C] Hypertension as a surrogate marker for the activity of anti-VEGF agents
O Mir, S Ropert, J Alexandre… - Annals of oncology …, 2009 - pubmed.ncbi.nlm.nih.gov
[引用][C] Hypertension as a surrogate marker for the activity of anti-VEGF agents.
O Mir, S Ropert, J Alexandre… - Annals of Oncology …, 2009 - europepmc.org
[引用][C] Hypertension as a surrogate marker for the activity of anti-VEGF agents
O Mir, S Ropert, J Alexandre, F Goldwasser - Annals of Oncology, 2009 - cir.nii.ac.jp
Hypertension as a surrogate marker for the activity of anti-VEGF agents | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …